ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AUPH Aurinia Pharmaceuticals Inc

4.995
-0.005 (-0.10%)
Last Updated: 05:28:21
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Aurinia Pharmaceuticals Inc AUPH NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.005 -0.10% 4.995 05:28:21
Open Price Low Price High Price Close Price Previous Close
4.99 4.97 5.04 5.00
more quote information »

Recent News

Date Time Source Heading
08/3/202408:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202408:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202408:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202408:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202408:10EDGAR2Form 8-K - Current report
01/3/202400:30BWAurinia Receives Exemptive Relief from Canadian Securities..
28/2/202400:30BWAurinia to Participate in Upcoming Investor Healthcare..
23/2/202408:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202408:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202408:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202408:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202408:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202408:19EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
15/2/202422:16EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15/2/202422:06EDGAR2Form 8-K - Current report
15/2/202422:00BWAurinia Discloses 2023 Year-End Financial and Operational..
15/2/202407:27EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/2/202400:30BWAurinia Pharmaceuticals to Release 2023 Fourth Quarter and..
05/1/202422:02EDGAR2Form 8-K - Current report
05/1/202422:00BWAurinia Provides Preliminary Unaudited Fourth Quarter and..
20/12/202322:00BWAurinia Submits IND Application to US Food & Drug..
13/11/202322:00BWAurinia Pharmaceuticals Announces Collaboration Partner..
08/11/202302:30BWAurinia Presents Breadth of Data from AURORA Clinical..
03/11/202309:00BWAurinia Presents Breadth of Data at ASN 2023 Demonstrating..
02/11/202321:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202321:01EDGAR2Form 8-K - Current report
02/11/202321:00BWAurinia Pharmaceuticals Reports Third Quarter and Nine..
27/10/202306:00BWAurinia Response in Support of 2023 Updated EULAR..
20/10/202301:31BWCORRECTING and REPLACING Aurinia Pharmaceuticals to Release..
19/10/202321:00BWAurinia Pharmaceuticals to Release Third Quarter Financial..
14/10/202303:00BWAurinia Pharmaceuticals Announces Presentations at American..
23/9/202306:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/9/202306:06EDGAR2Form 8-K - Current report
21/9/202320:00BWAurinia Board of Directors Appoints Dr. Robert T. Foster as..
22/8/202306:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/8/202306:11EDGAR2Form 8-K - Current report
21/8/202320:00BWAurinia Appoints Two New Board Directors with Deep..
03/8/202320:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202320:03EDGAR2Form 8-K - Current report
03/8/202320:00BWAurinia Pharmaceuticals Reports Second Quarter and Six..
20/7/202320:00BWAurinia Pharmaceuticals to Release Second Quarter Financial..
20/7/202302:05BWLong Term Phase 3 Data Published in Arthritis & Rheumatology..
06/7/202322:33EDGAR2Form PX14A6G - Notice of exempt solicitation submitted by..
03/7/202320:06EDGAR2Form 8-K - Current report
30/6/202306:05BWAurinia Board of Directors Announces Exploration of..
20/6/202323:00BWAurinia Showcases Three Oral Presentations for LUPKYNIS®..
01/6/202323:00BWLUPKYNIS® (voclosporin) Achieved Significantly Higher Renal..
27/5/202307:16BWAurinia Files Form S-8 to Register Shares Underlying..
18/5/202302:14BWAurinia Announces 2023 Annual General Meeting Results
09/5/202320:00BWAurinia Pharmaceuticals Announces Kidney Biopsies Sub-study..

Your Recent History

Delayed Upgrade Clock